COMPASS Pathways Granted Patent Covering Use of Its Psilocybin...
LONDON, January 13, 2020 /PRNewswire-AsiaNet/-- COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating drug-resistant depression with a psilocybin formulation, by the US Patent and Trademark Office. The p...
Authors: LATEST ASIANET NEWS RELEASES